These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25971525)

  • 1. Validation of Risk Scoring System Excluding Female Sex From CHA2DS2-VASc in Japanese Patients With Nonvalvular Atrial Fibrillation – Subanalysis of the J-RHYTHM Registry.
    Tomita H; Okumura K; Inoue H; Atarashi H; Yamashita T; Origasa H; Tsushima E;
    Circ J; 2015; 79(8):1719-26. PubMed ID: 25971525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of CHA₂DS₂-VASc and HAS-BLED scores in Japanese patients with nonvalvular atrial fibrillation: an analysis of the J-RHYTHM Registry.
    Okumura K; Inoue H; Atarashi H; Yamashita T; Tomita H; Origasa H;
    Circ J; 2014; 78(7):1593-9. PubMed ID: 24759791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA
    Nielsen PB; Skjøth F; Overvad TF; Larsen TB; Lip GYH
    Circulation; 2018 Feb; 137(8):832-840. PubMed ID: 29459469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of R
    Methavigul K; Sairat P; Krittayaphong R;
    BMC Cardiovasc Disord; 2021 Nov; 21(1):540. PubMed ID: 34772351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
    Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY
    Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the CHA2DS2-VA Score (Excluding Female Sex) in Nonvalvular Atrial Fibrillation Patients: A Nationwide Population-Based Study.
    Choi SY; Kim MH; Kim HB; Kang SY; Lee KM; Hyun KY; Yun SC
    J Clin Med; 2022 Mar; 11(7):. PubMed ID: 35407433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
    Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
    Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between CHADS2 and CHA2DS2-VASc score for risk stratification of ischemic stroke in Japanese patients with non-valvular paroxysmal atrial fibrillation not receiving anticoagulant therapy.
    Komatsu T; Sato Y; Ozawa M; Kunugita F; Yoshizawa R; Morino Y; Nakamura M
    Int Heart J; 2014; 55(2):119-25. PubMed ID: 24632957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHA2DS2-VASc Score, Warfarin Use, and Risk for Thromboembolic Events Among HIV-Infected Persons With Atrial Fibrillation.
    Chau KH; Scherzer R; Grunfeld C; Hsue PY; Shlipak MG
    J Acquir Immune Defic Syndr; 2017 Sep; 76(1):90-97. PubMed ID: 28797024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hypertrophic cardiomyopathy on the prediction of thromboembolism in patients with nonvalvular atrial fibrillation.
    Tsuda T; Hayashi K; Fujino N; Konno T; Tada H; Nomura A; Tanaka Y; Sakata K; Furusho H; Takamura M; Kawashiri MA; Yamagishi M;
    Heart Rhythm; 2019 Jun; 16(6):829-837. PubMed ID: 30503962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
    Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
    JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparison of CAS risk model and CHA
    Deng JL; He L; Jiang C; Lai YW; Long DY; Sang CH; Jia CQ; Feng L; Li X; Ning M; Hu R; Dong JZ; Du X; Tang RB; Ma CS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Sep; 50(9):888-894. PubMed ID: 36096706
    [No Abstract]   [Full Text] [Related]  

  • 14. CHA
    D'Souza M; Carlson N; Fosbøl E; Lamberts M; Smedegaard L; Nielsen D; Torp-Pedersen C; Gislason G; Schou M
    Eur J Prev Cardiol; 2018 Apr; 25(6):651-658. PubMed ID: 29482441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which risk score best predicts perioperative outcomes in nonvalvular atrial fibrillation patients undergoing noncardiac surgery?
    van Diepen S; Youngson E; Ezekowitz JA; McAlister FA
    Am Heart J; 2014 Jul; 168(1):60-7.e5. PubMed ID: 24952861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboembolic events in paroxysmal vs. permanent non-valvular atrial fibrillation. Subanalysis of the J-RHYTHM Registry.
    Inoue H; Atarashi H; Okumura K; Yamashita T; Kumagai N; Origasa H
    Circ J; 2014; 78(10):2388-93. PubMed ID: 25099606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors of thromboembolism in nonvalvular atrial fibrillation patients with low CHA2DS2-VASc score.
    Yan S; Li Q; Xia Z; Yan S; Wei Y; Hong K; Wu Y; Li J; Cheng X
    Medicine (Baltimore); 2019 Feb; 98(8):e14549. PubMed ID: 30813164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arterial Thromboembolism in Patients With Atrial Fibrillation and CHA
    Østergaard L; Olesen JB; Petersen JK; Nielsen LS; Kristensen SL; Schou M; Køber L; Fosbøl E
    Circulation; 2024 Mar; 149(10):764-773. PubMed ID: 38152890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHA
    Parsons C; Patel SI; Cha S; Shen WK; Desai S; Chamberlain AM; Luis SA; Aguilar MI; Demaerschalk BM; Mookadam F; Shamoun F
    Mayo Clin Proc; 2017 Mar; 92(3):360-369. PubMed ID: 28259228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation.
    Zhu WG; Xiong QM; Hong K
    Tex Heart Inst J; 2015 Feb; 42(1):6-15. PubMed ID: 25873792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.